Manas AI

Traditional drug development is inefficient, lacks scalability, and ultimately delays the delivery of life saving cures to patients in need. Manas AI was founded to address these shortcomings and pioneer a new paradigm of faster, cheaper, and more precise medicines. To realize this vision, Manas AI has assembled an unrivaled interdisciplinary team supported by a scientific advisory board of industry defining visionaries and stalwarts.

We leverage a combination of world-class biology, chemistry, medicinal knowledge, and foundational AI technologies to support a transformation across the full clinical pipeline. Spanning target identification, candidate generation, optimization, preclinical testing, and clinical trials, we carry a synergistic ethos of cutting-edge AI augmented by best-in-class biomedical expertise.

At the core of our company, we are building foundational, neuro-symbolic models built on first principles. These models codify deep scientific domain rules and enable the development of candidates across multiple established and emerging therapeutic modalities. Our generated candidates are supported by a global clinical trial ecosystem that prioritizes speed, efficiency, and safety.

There is a new model for drug development, and Manas AI is its pioneer.

Our approach

Science & technology

We build state of the art foundational AI models integrated with the deep domain rules from chemistry, physics, and biology.

End-to-End

Our products are medicines. We leverage AI in every step of the process from target ID to bringing life saving therapies in market.

Multiple therapeutic modalities

Our platform supports discovery and development across antibodies, nanobodies, small molecules, siRNAs, and combinatorial therapies.

International ecosystem

We leverage a global community of partners and collaborators to drive efficiency and safety in our clinical trials.

Humans in the loop

We augment our AI solutions with human expertise, intuition, and experience.